WEBCAST


New adventures in ROI measurement

Date: Thursday, March 26, 2009
Time: 2pm EST/11am PST

Click here to register for free

Featured Speaker:
Mauricio Ferreira, PhD, Head of Marketing Science Group, Hypothesis
Asaf Evenhaim, CEO, Chief Executive Officer, Crossix Solutions Inc.
Mike Wojeck, Vice President of Strategic Solutions, RealAge, Inc.

Sponsored by RealAge 

ENTER THE MM&M AWARDS




Don't miss your chance to prove to the industry and your clients who produces the best work. You must enter to win. The deadline for submissions is Friday, June 5. Click here to submit your entry today.

MM&M PODCAST SERIES


Do you love your job? Or do your loathe it?

Is your career on track? Are you making enough money? As much as your peers? What are you going to do next? Complete the MM&M Career & Salary Survey 2009 now for a chance to win a $250 American Express gift card. All responses are confidential.
Click here to take the survey.

TOP JOBS

To find out about the MM&M Careers Section contact:
Scott Dattoli at 646-638-6015

New Drug Dossier

Click here to subscribe

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. 

white Papers







MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Subscribe to MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Number of reps down 10% since 2007, says study

Job security for pharma sales reps is looking bleak, going by the results of a ZS Associates study. The survey found that the number of US reps has plummeted 10% since 2007 to 92,000, and the management consultancy projects a further decline, to 75,000 by 2012.
 

Pfizer taps Cephalon exec to head US oncology

Pfizer named Elizabeth Barrett regional president, US for its Oncology Business Unit, a new position, with responsibility for Pfizer's US oncology sales, field operations and marketing.
 

Iowa Senate passes harsh gifts, data ban bill

Iowa's state Senate passed a healthcare bill containing some of the toughest restrictions on drug company contacts with physicians yet.
 

FROM OUR SPONSORS


Search has Changed. It's Time for Healthcare Marketers to Stand Up and Take Notice. Incorporating social media into your search marketing efforts is no longer a luxury. Today, it's a necessity if you want your healthcare organization to be found online. Learn how to optimize your online presence and more in Oneupweb's FREE paper, The Fusion of Search and Social Media.

In Brief

People News

Accera, Inc., a biotech focused on central nervous system diseases, has announced the election of Thomas Werner to its board of directors. Werner was managing director and SVP of GlaxoSmithKline, and served as CEO of the GSK Foundation, until January of this year.
 

Company News

WebMD announced a partnership with Boots UK Limited, a pharmacy-led health and beauty retailer in the United Kingdom. The partnership will include a consumer health and wellness online portal in the UK. The service is expected to launch in the second half of 2009.
 

Product News

FDA OK'd a new indication for Eli Lilly's Symbyax, a Zyprexa and Prozac combination therapy. Symbyax is now indicated for patients with treatment-resistant depression, in addition to its prior indication for bipolar depression.
 

Latest Features

Sales Force Report: Training

E-learning is poised to replace traditional training models as pharma adjusts to a new landscape where sales reps need to be more technology savvy. Anthony Vecchione reports on how drug companies are incorporating different modalities, such as mobile learning and virtual worlds, into their training regimens
 

Sales Force Report: Effective Product Messages

An effective product message is the culmination of a process that starts with understanding the market and identifying where your product would fit in. Donna Kelly, Alice Liftin and Stacy Vaughn examine the research process
 

Statins: Making New Friends

Single agent statins are still the cornerstone of cholesterol treatment, but with generic Zocor gaining ground and Lipitor's approaching patent expiry, manufacturers are looking to take combinations to the next level. Ben Comer reports
 

Payers: Plan Early or Pay the Price

Drug firms should begin developing pricing, reimbursement and access strategies prior to launch. Kevin Barnett examines how addressing payer-related strategies early will help products succeed and provides guidance to managers who find themselves 'behind the eight-ball'
 

Medical Advertising Hall of Fame Induction 2009

Hundreds of healthcare advertising and publishing leaders gathered at New York's Pierre Hotel for a celebratory dinner to honor four of the industry's biggest superstars.
 

Headliner: Elsevier's Ed Silverman

A reporter for more than a quarter-century, Ed Silverman began covering the pharma industry for The Star-Ledger of New Jersey in 1995.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.